v3.26.3
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net loss $ (47,417) $ (51,924)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation, amortization, and impairment 405 418
Share-based compensation 7,339 6,248
Loss on extinguishment of debt 11,683 0
Issuance of warrants under the Purchase Agreement 916 0
Amortization of debt issuance costs and discounts 5,368 8,246
Other, net 189 0
Changes in operating assets and liabilities:    
Trade and other receivables, net 12,509 (4,413)
Inventories (1,140) (1,840)
Prepaid expenses and other assets 2,204 1,383
Accounts payable (21,092) 276
Accrued expenses and other liabilities (1,440) (2,058)
Deferred revenue (817) (299)
Net cash used for operating activities (31,293) (43,963)
Investing activities:    
Capital expenditures (848) (477)
Net cash used for investing activities (848) (477)
Financing activities:    
Proceeds from Common Stock issued under public equity offering-ATM, net 4,653 21,227
Proceeds from Common Stock issued under public equity offering, net 0 79,728
Proceeds from issuance of long-term debt under the Credit Agreement 54,337 0
Proceeds from issuance of warrants under the Credit Agreement 663 0
Proceeds from shares issued under employee stock purchase plan 70 50
Proceeds from exercise of stock options, net 50 346
Proceeds from exercise of warrants, net under the Securities Purchase Agreements 154 1,430
Repayment of debt principal - 13.5% Notes (45,000) 0
Debt exit fee paid - 13.5% Notes (2,000) 0
Premium paid to retire debt - 13.5% Notes (3,887) 0
Payments for financing costs (4,100) 0
Payments for lease liabilities and royalty obligations (28) (32)
Payments for taxes on share-based compensation, net (3,591) (792)
Net cash provided by financing activities 1,321 101,957
Net (decrease) increase in cash and cash equivalents (30,820) 57,517
Cash and cash equivalents:    
Cash and cash equivalents at beginning of period 121,169 71,546
Cash and cash equivalents at end of period 90,349 129,063
Supplemental disclosures of cash flow information:    
Cash payments for interest 3,677 4,574
Non-cash investing activities: capital expenditures in Accounts Payable 0 40
Costs associated with public offering in Accounts Payable $ 0 $ 265